
FactSet Research Systems Inc. (FDS) received an upgrade in Validea's Patient Investor model, based on Warren Buffett's strategy, with its rating increasing from 75% to 89%. This upgrade, driven by improved underlying fundamentals and valuation, signals increased interest from the strategy, which targets firms with long-term, predictable profitability and low debt. Notably, FDS passed all key financial tests, including earnings predictability, debt service, and free cash flow, reinforcing its alignment with the strategy's criteria for fundamentally strong companies.
FactSet Research Systems (FDS) has received a significant endorsement from Validea's Patient Investor model, with its rating, based on Warren Buffett's investment strategy, increasing from 75% to 89%. This upgrade is driven by favorable underlying fundamentals and valuation, moving the stock into a range of high interest for the model. The analysis highlights the company's exceptional financial health, as FDS passed all nine of the strategy's quantitative tests. These include critical measures such as Earnings Predictability, Debt Service, Return on Equity, and Free Cash Flow, indicating a business with consistent profitability, a strong balance sheet, and efficient capital management. The passing mark on Share Repurchase further underscores a shareholder-friendly capital allocation policy. As a financial data and analytics provider, FDS operates in a resilient industry, and this quant-based upgrade affirms that it exhibits the core characteristics of a durable, high-quality compounder sought by the Buffett philosophy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment